Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Breast Cancer

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 125 articles:
HTML format



Single Articles


    April 2021
  1. VARTANIAN ED, Lo AY, Hershenhouse KS, Jacob L, et al
    The role of neurotization in autologous breast reconstruction: Can reconstruction restore breast sensation?
    J Surg Oncol. 2021;123:1215-1231.
    PubMed     Abstract available


  2. YAMAMOTO T, Kageyama T, Sakai H, Fuse Y, et al
    Thoracoacromial artery and vein as main recipient vessels in deep inferior epigastric artery perforator (DIEP) flap transfer for breast reconstruction.
    J Surg Oncol. 2021;123:1232-1237.
    PubMed     Abstract available


    March 2021
  3. LYNCH KT, Kane WJ, Fleming MA, Desai RP, et al
    Childhood cancer survivors face markedly worse overall survival after diagnosis with breast cancer, melanoma, or colorectal cancer.
    J Surg Oncol. 2021 Mar 31. doi: 10.1002/jso.26478.
    PubMed     Abstract available


  4. VERDIAL FC, Bartek MA, Anderson BO, Javid SH, et al
    Genetic testing and surgical treatment after breast cancer diagnosis: Results from a national online cohort.
    J Surg Oncol. 2021 Mar 18. doi: 10.1002/jso.26372.
    PubMed     Abstract available


  5. NAKAMURA R, Hayama S, Sonoda I, Miyaki T, et al
    Clinical impact of the biology of synchronous axillary lymph node metastases in primary breast cancer on preoperative treatment strategy.
    J Surg Oncol. 2021 Mar 8. doi: 10.1002/jso.26438.
    PubMed     Abstract available


  6. MELE A, Fan B, Pardo J, Emhoff I, et al
    Axillary lymph node dissection in the era of immediate lymphatic reconstruction: Considerations for the breast surgeon.
    J Surg Oncol. 2021;123:842-845.
    PubMed    


    February 2021
  7. SANTIAGO L, Volk RJ, Checka CM, Black D, et al
    Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study.
    J Surg Oncol. 2021 Feb 12. doi: 10.1002/jso.26420.
    PubMed     Abstract available


  8. JACKSON DK, Li Y, Eskander MF, Tsung A, et al
    Racial disparities in low-value surgical care and time to surgery in high-volume hospitals.
    J Surg Oncol. 2021;123:676-686.
    PubMed     Abstract available


  9. WOESTE MR, Bhutiani N, Donaldson M, McMasters KM, et al
    Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
    J Surg Oncol. 2021;123:439-445.
    PubMed     Abstract available


    January 2021
  10. LEIPHRAKPAM PD, Chowdhury S, Wang J, Black JD, et al
    The role and therapeutic implications of PI3K signaling pathway in cancer.
    J Surg Oncol. 2021;123:39-41.
    PubMed    


  11. EYRICH NW, Sloss KR, Howard RA, Klueh MP, et al
    Opioid prescribing exceeds consumption following common surgical oncology procedures.
    J Surg Oncol. 2021;123:352-356.
    PubMed     Abstract available


  12. HANSSON E, Edvinsson AC, Elander A, Kolby L, et al
    First-year complications after immediate breast reconstruction with a biological and a synthetic mesh in the same patient: A randomized controlled study.
    J Surg Oncol. 2021;123:80-88.
    PubMed     Abstract available


    December 2020
  13. KHADER A, Chang SC, Santamaria-Barria J, Garland-Kledzik M, et al
    Delay in surgery is associated with axillary upstaging of clinically node negative breast cancer patients.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26332.
    PubMed     Abstract available


  14. CORONEOS CJ, Woodward WA, Wong FC, Caudle AS, et al
    Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26343.
    PubMed     Abstract available


  15. SONAGLI M, Cagnacci Neto R, Leite FPM, Makdissi FBA, et al
    The use of telemedicine to maintain breast cancer follow-up and surveillance during the COVID-19 pandemic.
    J Surg Oncol. 2020 Dec 17. doi: 10.1002/jso.26327.
    PubMed     Abstract available


  16. ROBERTS A, Baxter NN, Sutradhar R, Lau C, et al
    Reoperation cascade in postmastectomy breast reconstruction and its associated factors: Results from a long-term population-based study.
    J Surg Oncol. 2020;122:1300-1306.
    PubMed     Abstract available


  17. SISCO M
    The burden of postmastectomy breast reconstruction.
    J Surg Oncol. 2020;122:1298-1299.
    PubMed    


    November 2020
  18. ZHANG JQ, Plitas G
    Immunotherapeutic strategies in breast cancer: A clinical update.
    J Surg Oncol. 2020 Nov 6. doi: 10.1002/jso.26287.
    PubMed     Abstract available


  19. LEE J, Park HS, Lee H, Lee K, et al
    Axillary lymph node dissection using a robotic surgical system: Initial experience.
    J Surg Oncol. 2020;122:1252-1256.
    PubMed    


  20. BROYLES JM, Smith JM, Phillips BT, Mericli AF, et al
    The effect of sarcopenia on perioperative complications in abdominally based free-flap breast reconstruction.
    J Surg Oncol. 2020;122:1240-1246.
    PubMed     Abstract available


  21. ARCIERO CA, Diehl AH 3rd, Liu Y, Sun Q, et al
    Triple-negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple-negative breast cancers.
    J Surg Oncol. 2020;122:1232-1239.
    PubMed     Abstract available


    October 2020
  22. SUTTON TL, Schlitt A, Gardiner SK, Johnson N, et al
    Time to surgery following neoadjuvant chemotherapy for breast cancer impacts residual cancer burden, recurrence, and survival.
    J Surg Oncol. 2020 Oct 30. doi: 10.1002/jso.26216.
    PubMed     Abstract available


  23. LI X, Tan Q, Li H, Yang X, et al
    Predictive value of tumor-infiltrating lymphocytes for response to neoadjuvant chemotherapy and breast cancer prognosis.
    J Surg Oncol. 2020 Oct 12. doi: 10.1002/jso.26252.
    PubMed     Abstract available


  24. CORSO G, Frassoni S, Girardi A, De Camilli E, et al
    Metaplastic breast cancer: Prognostic and therapeutic considerations.
    J Surg Oncol. 2020 Oct 12. doi: 10.1002/jso.26248.
    PubMed     Abstract available


  25. ESGUEVA A, Siso C, Espinosa-Bravo M, Sobrido C, et al
    Leveraging the increased rates of pathologic complete response after neoadjuvant treatment in breast cancer to de-escalate surgical treatments.
    J Surg Oncol. 2020 Oct 1. doi: 10.1002/jso.26236.
    PubMed     Abstract available


  26. MASIA J
    The largest multicentre data collection on prepectoral breast reconstruction: The iBAG study.
    J Surg Oncol. 2020;122:848-860.
    PubMed     Abstract available


  27. ANDRADE WP, Goncalves GG, Medeiros LC, Araujo DCM, et al
    Low-cost, safe, and effective smoke evacuation device for surgical procedures in the COVID-19 age.
    J Surg Oncol. 2020;122:844-847.
    PubMed     Abstract available


    September 2020
  28. LEITE FPM, Curi C, Sanches SM, Curado MP, et al
    How to maintain elective treatment of breast cancer during the COVID-19 pandemic-A cancer center experience.
    J Surg Oncol. 2020 Sep 28. doi: 10.1002/jso.26233.
    PubMed    


  29. SINDONI A, Di Maria A, Fama' F
    Orbital metastases in infiltrating lobular carcinoma of the breast.
    J Surg Oncol. 2020;122:569.
    PubMed    


  30. AL-ARNAWOOT B, Scaranelo A, Fleming R, Kulkarni S, et al
    Cellular fibroepithelial lesions diagnosed on core needle biopsy: Is there any role of clinical-sonography features helping to differentiate fibroadenomas and phyllodes tumor?
    J Surg Oncol. 2020;122:382-387.
    PubMed     Abstract available


    August 2020
  31. BERGER JM, Longhitano Y, Zanza C, Sener SF, et al
    Factors affecting the incidence of chronic pain following breast cancer surgery: Preoperative history, anesthetic management, and surgical technique.
    J Surg Oncol. 2020 Aug 19. doi: 10.1002/jso.26176.
    PubMed     Abstract available


  32. CAVALCANTE FP, Novita GG, Millen EC, Zerwes FP, et al
    Breast cancer and COVID-19 pandemic in Brazil.
    J Surg Oncol. 2020 Aug 5. doi: 10.1002/jso.26143.
    PubMed    


  33. SPAUTZ CC, Schunemann Junior E, Budel LR, Cavalcanti TCS, et al
    Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary staging.
    J Surg Oncol. 2020;122:164-169.
    PubMed     Abstract available


    July 2020
  34. BERGMANN A, Baiocchi JMT, de Andrade MFC, Thuler LCS, et al
    Comment to "Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort".
    J Surg Oncol. 2020 Jul 22. doi: 10.1002/jso.26094.
    PubMed    


  35. BRUNELLE CL, Roberts SA, Shui AM, Gillespie TC, et al
    Reply to: Bergmann et al comment to "Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort".
    J Surg Oncol. 2020 Jul 22. doi: 10.1002/jso.26132.
    PubMed    


  36. FRASSON AL, Resende HM, Lichtenfels M, Barbosa F, et al
    Axillary management for patients with breast cancer after neoadjuvant chemotherapy: Results of a survey among Brazilian breast surgeons.
    J Surg Oncol. 2020 Jul 7. doi: 10.1002/jso.26104.
    PubMed     Abstract available


  37. KOPKASH K, Sisco M, Poli E, Seth A, et al
    The modern approach to the nipple-sparing mastectomy.
    J Surg Oncol. 2020;122:29-35.
    PubMed     Abstract available


  38. BOLAND MR, Ryan EJ, Nugent T, Gilroy D, et al
    Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer patients.
    J Surg Oncol. 2020 Jul 1. doi: 10.1002/jso.26096.
    PubMed     Abstract available


    June 2020
  39. HAMMOND JB, Parnall TH, Scott DW, Kosiorek HE, et al
    Gauging the efficacy of neoadjuvant endocrine therapy in breast cancer patients with known axillary disease.
    J Surg Oncol. 2020 Jun 7. doi: 10.1002/jso.26047.
    PubMed     Abstract available


  40. JAKUBOWSKI DM, Bailey H, Abran J, Blacklock A, et al
    Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score test.
    J Surg Oncol. 2020 Jun 4. doi: 10.1002/jso.26050.
    PubMed     Abstract available


  41. BRUNELLE CL, Roberts SA, Shui AM, Gillespie TC, et al
    Patients who report cording after breast cancer surgery are at higher risk of lymphedema: Results from a large prospective screening cohort.
    J Surg Oncol. 2020 Jun 4. doi: 10.1002/jso.25944.
    PubMed     Abstract available


  42. JIANG Z, Yin J
    Performance evaluation of texture analysis based on kinetic parametric maps from breast DCE-MRI in classifying benign from malignant lesions.
    J Surg Oncol. 2020;121:1181-1190.
    PubMed     Abstract available


    May 2020
  43. ALTUNDAG K
    Orbital metastases in breast cancer patients with invasive lobular carcinoma.
    J Surg Oncol. 2020 May 24. doi: 10.1002/jso.26042.
    PubMed    


  44. CHENG M, Zhuang X, Zhang L, Zhu T, et al
    A nomogram to predict non-sentinel lymph node metastasis in patients with initial cN+ breast cancer that downstages to cN0 after neoadjuvant chemotherapy.
    J Surg Oncol. 2020 May 20. doi: 10.1002/jso.25989.
    PubMed     Abstract available


  45. RESENDE PAULINELLI R, de Oliveira VM, Bagnoli F, Letzkus Berrios J, et al
    Oncoplastic mammaplasty with geometric compensation: Evolution of the technique, outcomes and follow-up in a multicentre retrospective cohort.
    J Surg Oncol. 2020;121:967-974.
    PubMed     Abstract available


    April 2020
  46. AHMED S, Pati S, Le D, Haider K, et al
    The prognostic and predictive role of 21-gene recurrence scores in hormone receptor-positive early-stage breast cancer.
    J Surg Oncol. 2020 Apr 28. doi: 10.1002/jso.25952.
    PubMed     Abstract available


  47. LADD MK, Peshkin BN, Isaacs C, Hooker G, et al
    Predictors of genetic testing uptake in newly diagnosed breast cancer patients.
    J Surg Oncol. 2020 Apr 28. doi: 10.1002/jso.25956.
    PubMed     Abstract available


  48. BHUTIANI N, Egger ME, Stromberg AJ, Bhutiani IK, et al
    Identifying factors impacting the efficacy of postmastectomy radiotherapy in patients with early-stage breast cancer and one to two positive lymph nodes.
    J Surg Oncol. 2020 Apr 25. doi: 10.1002/jso.25947.
    PubMed     Abstract available


  49. SINDONI A, Fama' F, Vinciguerra P, Dionigi G, et al
    Orbital metastases from breast cancer: A single institution case series.
    J Surg Oncol. 2020 Apr 15. doi: 10.1002/jso.25927.
    PubMed     Abstract available


    March 2020
  50. BHUTIANI N, Hicks AC, Huang B, Chen Q, et al
    Identifying factors influencing delays in breast cancer treatment in Kentucky following the 2014 Medicaid expansion.
    J Surg Oncol. 2020 Mar 29. doi: 10.1002/jso.25914.
    PubMed     Abstract available


  51. SQUITIERI L, Rasmussen PW, Patel KM
    An economic analysis of prophylactic lymphovenous anastomosis among breast cancer patients receiving mastectomy with axillary lymph node dissection.
    J Surg Oncol. 2020 Mar 23. doi: 10.1002/jso.25902.
    PubMed     Abstract available


  52. WECSLER J, Jeong YJ, Raghavendra AS, Mack WJ, et al
    Factors associated with MRI detection of occult lesions in newly diagnosed breast cancers.
    J Surg Oncol. 2020;121:589-598.
    PubMed     Abstract available


    February 2020
  53. JIANG L, Liu T, Wang X, Li J, et al
    Real-time near-infrared fluorescence imaging mediated by blue dye in breast cancer patients.
    J Surg Oncol. 2020 Feb 26. doi: 10.1002/jso.25874.
    PubMed     Abstract available


  54. ALTUNDAG K
    Late relapse rates in patients with early-stage hormone receptor-positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy.
    J Surg Oncol. 2020 Feb 17. doi: 10.1002/jso.25857.
    PubMed    


  55. BURKBAUER L, Goldbach M, Pomponio M, Tchou J, et al
    Response to "Late relapse rates in patients with early-stage hormone receptor positive and HER2+ breast cancer treated with adjuvant chemotherapy and neoadjuvant chemotherapy".
    J Surg Oncol. 2020 Feb 17. doi: 10.1002/jso.25867.
    PubMed    


    January 2020
  56. WANG K, Dai Y, Pan Y, Cheng P, et al
    Local-regional recurrence risk after autologous fat grafting in breast cancer patients: A systematic review and meta-analysis.
    J Surg Oncol. 2020 Jan 14. doi: 10.1002/jso.25829.
    PubMed     Abstract available


  57. POMPONIO MK, Burkbauer L, Goldbach M, Nazarian SM, et al
    Refining the indications for neoadjuvant chemotherapy for patients with HER2+ breast cancer: A single institution experience.
    J Surg Oncol. 2020 Jan 9. doi: 10.1002/jso.25814.
    PubMed     Abstract available


    December 2019
  58. KANDA MH, da Costa Vieira RA, Lima JPSN, Paiva CE, et al
    Late locoregional complications associated with adjuvant radiotherapy in the treatment of breast cancer: Systematic review and meta-analysis.
    J Surg Oncol. 2019 Dec 26. doi: 10.1002/jso.25820.
    PubMed     Abstract available


  59. ROY M, Sebastiampillai S, Haykal S, Zhong T, et al
    Development and validation of a risk stratification model for immediate microvascular breast reconstruction.
    J Surg Oncol. 2019;120:1177-1183.
    PubMed     Abstract available


  60. TARUNO K, Kurita T, Kuwahata A, Yanagihara K, et al
    Multicenter clinical trial on sentinel lymph node biopsy using superparamagnetic iron oxide nanoparticles and a novel handheld magnetic probe.
    J Surg Oncol. 2019;120:1391-1396.
    PubMed     Abstract available


    November 2019
  61. EAGLEHOUSE YL, Georg MW, Jatoi I, Shriver CD, et al
    Factors related to re-excision procedures following primary breast-conserving surgery for women with breast cancer in the U.S. Military Health System.
    J Surg Oncol. 2019 Nov 29. doi: 10.1002/jso.25788.
    PubMed     Abstract available


  62. LIN JY, Yang X, Serra M, Miller AH, et al
    Full axillary lymph node dissection and increased breast epidermal thickness 1 year after radiation therapy for breast cancer.
    J Surg Oncol. 2019 Nov 8. doi: 10.1002/jso.25757.
    PubMed     Abstract available


  63. DIONYSSIOU D, Demiri E, Sarafis A, Goula CO, et al
    Functional lymphatic reconstruction with the "Selected Lymph Node" technique guided by a SPECT-CT lymphoscintigraphy.
    J Surg Oncol. 2019;120:911-918.
    PubMed     Abstract available


    September 2019
  64. RATTI F, Serenari M, Zanello M, Prosperi E, et al
    Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases.
    J Surg Oncol. 2019 Sep 9. doi: 10.1002/jso.25702.
    PubMed     Abstract available


  65. ZHOU L, Wang Y, Cai R, Huang J, et al
    Pedicled descending branch latissimus dorsi mini-flap in repairing partial mastectomy defect: Shoulder functional and esthetic outcomes.
    J Surg Oncol. 2019;120:518-526.
    PubMed     Abstract available


  66. EBNER PJ, Liu A, Gould DJ, Patel KM, et al
    Breast implant-associated anaplastic large cell lymphoma, a systematic review and in-depth evaluation of the current understanding.
    J Surg Oncol. 2019;120:573-577.
    PubMed     Abstract available


  67. MURPHY BL, Thiels CA, Hanson KT, McLaughlin S, et al
    Pain and opioid prescriptions vary by procedure after breast surgery.
    J Surg Oncol. 2019;120:593-602.
    PubMed     Abstract available


  68. FAYANJU OM, Williamson HV
    Response to Letter to the Editor: "The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma".
    J Surg Oncol. 2019;120:566.
    PubMed    


  69. ALTUNDAG K
    Patients with invasive lobular and ductal carcinoma or pleomorphic lobular carcinoma might increase pathologic complete response rate and lower mastectomy rates compared to classical lobular type.
    J Surg Oncol. 2019;120:565.
    PubMed    


    August 2019
  70. SANTIAGO L, Adrada BE, Caudle AS, Clemens MW, et al
    The role of three-dimensional printing in the surgical management of breast cancer.
    J Surg Oncol. 2019 Aug 22. doi: 10.1002/jso.25680.
    PubMed     Abstract available


  71. SENER SF, Sargent RE, Lee C, Manchandia T, et al
    MRI does not predict pathologic complete response after neoadjuvant chemotherapy for breast cancer.
    J Surg Oncol. 2019 Aug 9. doi: 10.1002/jso.25663.
    PubMed     Abstract available


  72. SCHWARZ GS, Grobmyer SR, Djohan RS, Cakmakoglu C, et al
    Axillary reverse mapping and lymphaticovenous bypass: Lymphedema prevention through enhanced lymphatic visualization and restoration of flow.
    J Surg Oncol. 2019;120:160-167.
    PubMed     Abstract available


  73. KRAENZLIN FS, Saunders H, Aliu O, Cooney D, et al
    Classification of breast tissue expander infections: Back to the basics.
    J Surg Oncol. 2019;120:142-147.
    PubMed     Abstract available


  74. TAMIRISA N, Williamson HV, Thomas SM, Westbrook KE, et al
    The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma.
    J Surg Oncol. 2019;120:132-141.
    PubMed     Abstract available


    July 2019
  75. VAN DEN HOVEN I, van Klaveren D, Verheuvel NC, van la Parra RFD, et al
    Predicting the extent of nodal involvement for node positive breast cancer patients: Development and validation of a novel tool.
    J Surg Oncol. 2019 Jul 23. doi: 10.1002/jso.25644.
    PubMed     Abstract available


  76. MOUSAVI SR, Akbari ME, Zarrintan S
    Vascularized gastroepiploic lymph node transfer significantly improves breast cancer-related lymphedema.
    J Surg Oncol. 2019 Jul 16. doi: 10.1002/jso.25607.
    PubMed     Abstract available


  77. HOUPU Y, Fei X, Yang Y, Fuzhong T, et al
    Use of Memorial Sloan Kettering Cancer Center nomogram to guide intraoperative sentinel lymph node frozen sections in patients with early breast cancer.
    J Surg Oncol. 2019 Jul 16. doi: 10.1002/jso.25638.
    PubMed     Abstract available


  78. LEE TC, Reyna C, Shaughnessy E, Lewis JD, et al
    Screening of populations at high risk for breast cancer.
    J Surg Oncol. 2019 Jul 8. doi: 10.1002/jso.25611.
    PubMed     Abstract available


    June 2019
  79. SENER SF
    Advances in axillary surgery for breast cancer 2019.
    J Surg Oncol. 2019 Jun 25. doi: 10.1002/jso.25591.
    PubMed     Abstract available


  80. LIN CY, Liu HE, Cheng MH
    Factors associated with professional healthcare advice seeking in breast cancer-related lymphedema.
    J Surg Oncol. 2019 Jun 18. doi: 10.1002/jso.25523.
    PubMed     Abstract available


  81. ZHAO B, Tsai C, Hunt KK, Blair SL, et al
    Adherence to surgical and oncologic standards improves survival in breast cancer patients.
    J Surg Oncol. 2019 Jun 6. doi: 10.1002/jso.25506.
    PubMed     Abstract available


  82. CORSI F, Bossi D, Combi F, Papadopoulou O, et al
    Radio-guided vs clip-guided localization of nonpalpable mass-like lesions of the breast from a screened population: A propensity score-matched study.
    J Surg Oncol. 2019;119:916-924.
    PubMed     Abstract available


  83. CHAUDHRY A, Oliver JD, Vyas KS, Alsubaie SA, et al
    Outcomes analysis of Goldilocks mastectomy and breast reconstruction: A single institution experience of 96 cases.
    J Surg Oncol. 2019;119:1047-1052.
    PubMed     Abstract available


    May 2019
  84. BRUENDERMAN EH, Bhutiani N, Mercer MK, McMasters KM, et al
    Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery.
    J Surg Oncol. 2019;119:694-699.
    PubMed     Abstract available


    March 2019
  85. ZHONG W, Tan L, Jiang WG, Chen K, et al
    Effect of younger age on survival outcomes in T1N0M0 breast cancer: A propensity score matching analysis.
    J Surg Oncol. 2019 Mar 20. doi: 10.1002/jso.25457.
    PubMed     Abstract available


  86. VIEIRA RAC, Boni RADS, Silva VD
    Reply: ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall based on a systematic review of thoracoabdominal flaps.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25436.
    PubMed    


  87. BURATTINI ACB, Horacio GS, Beloti TR
    Reply: ITADE flap after mastectomy for locally advanced breast cancer: A good choice for mid-sized defects of the chest wall, based on a systematic review of thoracoabdominal flaps.
    J Surg Oncol. 2019 Mar 18. doi: 10.1002/jso.25439.
    PubMed    


  88. TAN MG, Isaranuwatchai W, DeLyzer T, Butler K, et al
    A cost-effectiveness analysis of DIEP vs free MS-TRAM flap for microsurgical breast reconstruction.
    J Surg Oncol. 2019;119:388-396.
    PubMed     Abstract available


  89. BANKS A, Coronado G, Zimmerman R, Iyengar G, et al
    Breast conserving surgery with targeted intraoperative radiotherapy for the management of ductal carcinoma in situ.
    J Surg Oncol. 2019;119:409-420.
    PubMed     Abstract available


    February 2019
  90. PARK KU, Kyrish K, Terrell J, Yi M, et al
    Surgeon perception versus reality: Opioid use after breast cancer surgery.
    J Surg Oncol. 2019 Feb 8. doi: 10.1002/jso.25395.
    PubMed     Abstract available


    January 2019
  91. DASGUPTA H, Islam S, Alam N, Roy A, et al
    Hypomethylation of mismatch repair genes MLH1 and MSH2 is associated with chemotolerance of breast carcinoma: Clinical significance.
    J Surg Oncol. 2019;119:88-100.
    PubMed     Abstract available


    December 2018
  92. HELLINGMAN D, de Wit-van der Veen BJ, Wan OY, van der Ploeg IM, et al
    Sentinel lymph node nonvisualization after intratumoral radioisotope tracer injection in breast cancer is not associated with a higher nodal metastasis rate or worse outcomes.
    J Surg Oncol. 2018 Dec 24. doi: 10.1002/jso.25339.
    PubMed     Abstract available


  93. LAWS A, Brar MS, Bouchard-Fortier A, Leong B, et al
    Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
    J Surg Oncol. 2018;118:1205-1211.
    PubMed     Abstract available


  94. JIN L, Wu X, Zha L, Feng Y, et al
    Adjacent skin rotation flap for large defect in primary breast tumor.
    J Surg Oncol. 2018;118:1199-1204.
    PubMed     Abstract available


    November 2018
  95. BERGER ER, Bilimoria KY, Kinnier CV, Minami CA, et al
    Assessment of hospital-level adjusted breast cancer sentinel lymph node positivity rates.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25294.
    PubMed     Abstract available


  96. PANCHAL H, Pilewskie ML, Sheckter CC, Albornoz CR, et al
    National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
    J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25315.
    PubMed     Abstract available


  97. YU TJ, Liu YY, Hu X, Di GH, et al
    No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma.
    J Surg Oncol. 2018;118:928-935.
    PubMed     Abstract available


  98. OLASEHINDE O, Alatise O, Arowolo O, Adisa A, et al
    Safety and feasibility of early postmastectomy discharge and home drain care in a low resource setting.
    J Surg Oncol. 2018;118:861-866.
    PubMed     Abstract available


  99. XU F, Sun H, Zhang C, Jiang H, et al
    Comparison of surgical complication between immediate implant and autologous breast reconstruction after mastectomy: A multicenter study of 426 cases.
    J Surg Oncol. 2018;118:953-958.
    PubMed     Abstract available


  100. MAY M, Chin C, Hirji S, Horowitz D, et al
    Comparing preoperative imaging modalities in patient selection for breast intraoperative radiotherapy.
    J Surg Oncol. 2018;118:959-965.
    PubMed     Abstract available


    October 2018
  101. JOHNSON AR, Singhal D
    Immediate lymphatic reconstruction.
    J Surg Oncol. 2018;118:750-757.
    PubMed     Abstract available


    September 2018
  102. BEAR HD, Wan W, Robidoux A, Rubin P, et al
    Re: Using the 21-gene assay from core needle biopsies to choose neoadjuvant therapy for breast cancer: A multicenter trial. Journal of Surgical Oncology 2017;115(8):917-923.
    J Surg Oncol. 2018;118:722.
    PubMed    


  103. HO OA, Lin YL, Pappalardo M, Cheng MH, et al
    Nipple-sparing mastectomy and breast reconstruction with a deep inferior epigastric perforator flap using thoracodorsal recipient vessels and a low lateral incision.
    J Surg Oncol. 2018;118:621-629.
    PubMed     Abstract available


    August 2018
  104. OHASHI R, Namimatsu S, Sakatani T, Naito Z, et al
    Prognostic utility of atypical mitoses in patients with breast cancer: A comparative study with Ki67 and phosphohistone H3.
    J Surg Oncol. 2018 Aug 11. doi: 10.1002/jso.25152.
    PubMed     Abstract available


    July 2018
  105. SUSNIK B, Schneider L, Swenson KK, Krueger J, et al
    Predictive value of breast magnetic resonance imaging in detecting mammographically occult contralateral breast cancer: Can we target women more likely to have contralateral breast cancer?
    J Surg Oncol. 2018;118:221-227.
    PubMed     Abstract available


  106. YOON-FLANNERY K, DeStefano LM, De La Cruz LM, Fisher CS, et al
    Quality of life and sexual well-being after nipple sparing mastectomy: A matched comparison of patients using the breast Q.
    J Surg Oncol. 2018;118:238-242.
    PubMed     Abstract available


  107. SMITH JR, Jaffe J, Pruitt J, Yao K, et al
    The effect of contralateral prophylactic mastectomy on breast-related charges: A 5-year analysis.
    J Surg Oncol. 2018;118:212-220.
    PubMed     Abstract available


    June 2018
  108. FUJIMOTO Y, Higuchi T, Nishimukai A, Miyagawa Y, et al
    High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
    J Surg Oncol. 2018 Jun 24. doi: 10.1002/jso.25125.
    PubMed     Abstract available


  109. ROSTAS JW, Bhutiani N, Crigger M, Crawford SMW, et al
    Calculation of breast volumes from mammogram: Comparison of four separate equations relative to mastectomy specimen volumes.
    J Surg Oncol. 2018;117:1848-1853.
    PubMed     Abstract available


    May 2018
  110. SHEN S, Xu Q, Zhou Y, Mao F, et al
    Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer.
    J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25058.
    PubMed     Abstract available


    April 2018
  111. VOLDERS JH, Negenborn VL, Haloua MH, Krekel NMA, et al
    Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.
    J Surg Oncol. 2018;117:1001-1008.
    PubMed     Abstract available


    March 2018
  112. ALTUNDAG K
    Breast cancer subtypes and local recurrence rate after surgery for bone metastasis to the extremities.
    J Surg Oncol. 2018 Mar 30. doi: 10.1002/jso.24987.
    PubMed    


  113. FOSTER D, Choy N, Porter C, Ahmed S, et al
    Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    J Surg Oncol. 2018;117:336-340.
    PubMed     Abstract available


  114. SO A, De La Cruz LM, Williams AD, Bahng J, et al
    The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
    J Surg Oncol. 2018;117:558-566.
    PubMed     Abstract available


    February 2018
  115. PERCY DB, Pao JS, McKevitt E, Dingee C, et al
    Number of nodes in sentinel lymph node biopsy for breast cancer: Are surgeons still biased?
    J Surg Oncol. 2018 Feb 26. doi: 10.1002/jso.25010.
    PubMed     Abstract available


    December 2017
  116. GERVAIS MK, Burtenshaw SM, Maxwell J, Dickson BC, et al
    Clinical outcomes in breast angiosarcoma patients: A rare tumor with unique challenges.
    J Surg Oncol. 2017;116:1056-1061.
    PubMed     Abstract available


  117. GIANNINI V, Bianchi V, Carabalona S, Mazzetti S, et al
    MRI to predict nipple-areola complex (NAC) involvement: An automatic method to compute the 3D distance between the NAC and tumor.
    J Surg Oncol. 2017;116:1069-1078.
    PubMed     Abstract available


  118. ALVARADO M, Lucci A, Manders J
    Best practices for multidisciplinary integration of a DCIS genomic assay into clinical practice.
    J Surg Oncol. 2017;116:1016-1020.
    PubMed     Abstract available


  119. PATTEN CR, Walsh K, Sarantou T, Hadzikadic-Gusic L, et al
    Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice.
    J Surg Oncol. 2017;116:1040-1045.
    PubMed     Abstract available


  120. HWANG H, Park S, Koo JS, Park HS, et al
    Factors predictive of occult nipple-areolar complex involvement in patients with carcinoma in situ of the breast.
    J Surg Oncol. 2017;116:1046-1055.
    PubMed     Abstract available


    November 2017
  121. TATARA T, Mukohara T, Shimono Y, Yamasaki T, et al
    Expression of programmed death-1 in sentinel lymph nodes of breast cancer.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24937.
    PubMed     Abstract available


  122. ONEGA T, Weiss JE, Goodrich ME, Zhu W, et al
    Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer.
    J Surg Oncol. 2017 Nov 11. doi: 10.1002/jso.24796.
    PubMed     Abstract available


    October 2017
  123. LEE S, Jung Y, Bae Y
    Immediate chest wall reconstruction using an external oblique myocutaneous flap for large skin defects after mastectomy in advanced or recurrent breast cancer patients: A single center experience.
    J Surg Oncol. 2017 Oct 29. doi: 10.1002/jso.24830.
    PubMed     Abstract available


  124. ALTUNDAG K
    Is HER2 loss after neoadjuvant chemotherapy determinant for the choice of adjuvant treatment in HER2 positive breast cancer patients?
    J Surg Oncol. 2017 Oct 2. doi: 10.1002/jso.24839.
    PubMed    


    September 2017
  125. NOGUCHI M, Ohno Y, Morioka E, Noguchi M, et al
    A novel oncoplastic technique for breast cancer localized in the lower pole of the breast.
    J Surg Oncol. 2017 Sep 20. doi: 10.1002/jso.24824.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: